Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial

BACKGROUND: Despite major advances in transplant medicine, improvements in long-term kidney allograft survival have not been commensurate with those observed shortly after transplantation. The formation of donor-specific antibodies (DSA) and ongoing antibody-mediated rejection (AMR) processes may cr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eskandary, Farsad, Bond, Gregor, Schwaiger, Elisabeth, Kikic, Zeljko, Winzer, Christine, Wahrmann, Markus, Marinova, Lena, Haslacher, Helmuth, Regele, Heinz, Oberbauer, Rainer, Böhmig, Georg A
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4014747/
https://ncbi.nlm.nih.gov/pubmed/24708575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-107
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars